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Abstract
Background: The potential role of oral vaccination of dogs against rabies in the Philippines was
investigated in terms of safety and efficacy.
Methods: Prior to the vaccination campaign, a house-to-house survey was carried out to collect
data on the dog population in the study area, the coastal village of Mindoro. During the vaccination
campaign all households were visited again, and all dogs encountered (>2 months old) were, if
possible, vaccinated. Furthermore, 14 dogs vaccinated were bled on different occasions.
Results: During the survey, a total of 216 dogs were counted, and none of these animals had
previously been vaccinated against rabies. Only 17 dogs could be restrained and subsequently
vaccinated directly by the vaccinators. Another 126 dogs were offered a local-made boiled intestine
bait, containing a capsule filled with 3.0 ml SAD B19 (107.9 FFU/ml). The bait acceptance rate of
dogs offered a bait was 96.1%. The vaccination coverage of the dog population (> 2 months old)
estimated by the number of animals vaccinated directly and the number of dogs that accepted a bait
and subsequently punctured the vaccine container was 76%. Fifteen and 29 days after the
vaccination campaign 6 and 10 dogs (n = 14) had rabies virus neutralizing antibody titres of ≥  0.5
IU/ml, respectively. No unintentional contacts of nontarget species, including humans, with the
vaccine virus were reported.
Conclusions: The results of the campaign show that oral vaccination of dogs against rabies is a
promising supplementary method in dog rabies control in the Philippines.
Background
The number of human deaths due to rabies is estimated
between 40,000 and 60,000 annually [1], 98% of these
cases are attributable to the bite of a rabid dog [2]. Al-
though significant progress in dog rabies control has
been reported from many countries, in others little or no
progress is made. Partly, because a large segment of the
dog population is not accessible for traditional vaccina-
tion by the parenteral route. For these countries oral vac-
cination of dogs (OVD) has been proposed as a
supplementary policy to parenteral vaccination, in the
hope of increasing the overall vaccination coverage of the
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dog population involved. Oral vaccination programmes
have been successful in eradicating wildlife rabies in
large areas of Europe and North-America [3–5].
In recent years, the World Health Organization (WHO)
has provided general guidelines that include planning
and organization of field trials with OVD [6]. OVD field
trials have been conducted in Turkey, South Africa, Sri
Lanka and Thailand [1]. The responsible authorities in
the Philippines have also been interested in this novel
technique. Here, dog rabies is widely distributed and ap-
plication of traditional control measures have yielded
less than optimal results. While the Philippines qualified
for the use of OVD as described by the WHO criteria [6],
it was decided to conduct a field trial. The first steps for
implementing OVD projects are; to select a candidate
vaccine, to test its safety and efficacy, to select a bait well
accepted by the local dog population, and to evaluate
bait-uptake in the target population. Thus, prior to this
field trial, the safety and efficacy of the vaccine virus can-
didate was tested in target and nontarget species (Estra-
da, unpublished results), and a bait made from cheap
locally available material was identified and tested under
field conditions [7]. It was decided to use a bait delivery
system that maximizes bait-availability to the target pop-
ulation, meanwhile minimizing the possibilities of con-
tact with the vaccine virus and/or vaccine baits by
nontarget species, especially humans. This system, going
house-to-house and offering a bait to every free-roaming
or restricted dog encountered that is not accessible for
parenteral vaccination, was developed and tested in Tur-
key [8,9].
Although no standard protocol for OVD field trials is
presently available, it was decided to incorporate as
many suggestions on OVD field trials made by WHO as
possible. Thus, the trial included data collection on dog
biology (dog density, population structure and dog : hu-
man ratio), bait distribution (training of personnel, bait
delivery system, costs of baits, acceptance by local hu-
man populations), risk assessment (possible exposure of
nontarget species to baits), and efficacy (vaccination cov-
erage) [10]. The protocol of the OVD-trial has received
approval of all regulatory and other local and national
authorities in the Philippines concerned. Furthermore,
prior to the field trial the active support of the local com-
munity and – authorities was guaranteed.
Study area
Mindoro is part of the municipality of the city of Bangar,
in the northern part of the province La Union, Philip-
pines (Figure 1). The village is situated at the coast of the
Chinese Sea in the estuary of the Amburayan river. It was
decided to conduct this field trial shortly before the rainy
season. Due to the rain, the riverbed of the Amburayan
river will be flooded and the island will be completely iso-
lated from the mainland. Thus, the river and the sea will
act as a kind of safety barrier. According to a census con-
ducted in 2000, the total human population of Mindoro
was 1480, divided over 304 households. Since 1995, no
rabies case has been reported from Mindoro itself. How-
ever, rabies is endemic in the province of La Union. In
this area, 23 dogs and 1 human were reported rabies pos-
itive during the first three months of 2001.
Materials and Methods
Dog population
Fortunately, there were no ownerless dogs in Mindoro,
so complicated mark-recapture models to estimate dog
population size were not necessary, a simple house-to-
house survey was sufficient. Information was gathered
on the following subjects; number of dogs and humans,
level of supervision, age and sex of dogs, vaccination sta-
tus.
Figure 1
Location of Mindoro, La Union, in the Philippines, where the
first oral vaccination campaign was conducted.BMC Infectious Diseases 2001, 1:23 http://www.biomedcentral.com/1471-2334/1/23
Vaccine baits
The WHO Collaborating Centre for Rabies Surveillance
and Research in Tübingen, Germany, introduced the oral
rabies vaccine virus SAD B19 as a possible candidate for
OVD [11]. The SAD B19 vaccine virus is a derivative of the
original SAD virus (Street-Alabama-Dufferin). The latter
was isolated from a rabid dog in 1935 in Alabama, USA,
and after passaging adapted to Baby-Hamster-Kidney
(BHK) 21 cells [12,13]. SAD B19 is globally the most
widely used oral rabies vaccine virus; since 1983 more
than 100 million SAD B19 vaccine baits have been dis-
tributed in more than 15 countries [14]. During intensive
laboratory – and field trials, the feasibility of OVD with
SAD B19 has been tested and proven in Turkey [8,11,15–
20]. The vaccine container (± 6.5 ×  3.0 ×  0.7 cm), a poly-
vinyl chloride capsule with serrated edges and sealed
with an aluminium cover foil, contained 3 ml SAD B19
(107.9 Foci Formatting Units [FFU] /ml). The capsules
were slid into the baits; boiled sections of the large intes-
tine of pigs [7]. The acceptability of these baits have been
assessed during previous bait trials in the Philippines;
98% of all dogs accepted the bait without hesitation [7].
Vaccination campaign
Eight vaccination teams, consisting out of two persons
each, visited all households. Every dog (> 2 months of
age) encountered that could not be handled by the vacci-
nators and/or owners was offered a bait by one of the
vaccinators after obtaining informed consent from the
owner. Afterwards, if possible, the discarded vaccine
container was collected by a vaccinator wearing exami-
nation gloves and who had received rabies pre-exposure
treatment. The vaccine baits were kept in a cool box. The
result of the vaccination attempt was recorded, together
with the name of the owner.
To assess the vaccination coverage, blood samples were
taken from a number of dogs prior to and on the day of
the campaign and from the animals on two occasions af-
terwards (15 and 29 days post vaccination). Virus neu-
tralizing antibodies (VNA) titres were determined by the
rapid fluorescence focus inhibition test (RFFIT) [21],
with the modifications of that method as described by
Cox and Schneider [22]. The titres were converted to In-
ternational Units (IU/ml). In this study, dogs with titres
of ≥  0.5 IU/ml were considered immune and protected
against rabies infection.
Risk assessment
Dogs are very closely associated with humans, therefore
safety requirements are more stringent for OVD than for
oral vaccination of wildlife [23]. To assess the safety of
the field trial the following parameters have been used:
(1) the absence of vaccine virus induced rabies in target
and nontarget species, and (2) the absence of human ex-
posure to the vaccine baits and – virus. Prior to the cam-
paign, all appropriate local officials (including public
health officials and teachers) were informed in detail.
Furthermore, advice aiming at avoiding contacts be-
tween freshly vaccinated dogs and humans (esp. chil-
dren) was given to the household members present
during the vaccination attempt. They were also told, not
to pick up (discarded) vaccine containers not recollected.
If people would somehow come in contact accidentally
with the vaccine virus they should report this to the local
officials. Two days after the vaccination campaign Mind-
oro was visited again and the local officials were inter-
viewed if people had reported contacts with freshly
vaccinated dogs or if any adverse reaction in the vacci-
nated animals had been observed.
To detect possible vaccine virus induced rabies in dogs or
other nontarget species, it was decided to collect as many
animals as possible that showed signs of illness or died
during a period of three months post vaccination cam-
paign. Afterwards the brain of these animals, if possible,
were examined for viral antigen by the fluorescence anti-
body test (FAT) [24].
Results
Dog population
The dog : human ratio was 1 : 6.9. 121 (39.8%) of 304
households claimed to own one or more dogs. A total of
216 animals were counted; 175 animals older than 2
months and 41 puppies (≤  2 months). An estimation of
the dog density can not be given, while the area that is
utilized by the dogs changed in time, due to changing wa-
ter levels. However, activities of the dogs were largely re-
stricted to the village and its direct surroundings. The
overall sex ratio was significantly biased towards fe-
males; 1 : 1.72 (male : female); χ 2 = 11.61, df = 1, n = 158,
P < 0.001. Of the 48 adult dogs present (≥  1 year old),
only 4 animals were males. However, the sex ratio of
dogs less than one year did not differ significantly from
unity; 1 : 1.02 (male : female). The average age of the
male (n = 50) and female (n = 90) dogs was 0.4 ± 0.6 and
1.7 ± 2.2 years, respectively. 66% of the dogs were aged
less than one year old. These figures indicate a very high
'disappearance-rate', especially among the males. No
ownerless dogs were observed. Furthermore, according
to the owners none of the dogs had been previously vac-
cinated against rabies and all dogs were unrestricted.
Most dogs originated from Mindoro, but 17.6% of the an-
imals were imported from other areas, including rabies-
infected areas. Dogs were generally in a very poor condi-
tion; only a few animals did not show clinical symptoms
of sarcoptic mange.BMC Infectious Diseases 2001, 1:23 http://www.biomedcentral.com/1471-2334/1/23
Vaccination-campaign
The 41 puppies (≤  2 months old) were too young to be
vaccinated, thus 175 dogs were eligible for vaccination.
To assess the efficiency of the oral vaccination campaign,
it was necessary to estimate the numbers of animals that
could be vaccinated by the parenteral route. Only 9.7% (n
= 17) of these 175 dogs could be caught and restrained by
the vaccinators without much problems. However, the
dog owners refused to assist and constrain these ani-
mals, afraid to be bitten. All these animals were between
2–4 months old. These 17 dogs were however not vacci-
nated by the parenteral route but were vaccinated by di-
rect instillation of the vaccine virus into the mouth
cavity, in order to make sure that enough serological data
of orally vaccinated dogs could be collected.
Of the remaining 158 dogs 126 animals could be relocat-
ed and were offered a bait. The animals offered a bait
were not marked individually, therefore three dogs were
accidentally offered a bait twice. Of the 129 oral vaccina-
tion attempts, only 5 dogs ran away or refused the bait;
indicating an overall bait acceptance of 96.1%. Another
four dogs accepted the bait, but walked away with it, so
the fate of the bait could not be recorded and subse-
quently the (discarded) vaccine container could not be
recollected. Four dogs swallowed the bait immediately,
hence it was presumed that the vaccine container was
not punctured. These dogs were therefore not considered
vaccinated. Another 13 dogs swallowed the vaccine con-
tainer after prolonged chewing and it was assumed that
the vaccine virus was released into the oral cavity. The
remaining 103 dogs accepted the bait and discarded the
punctured vaccine container afterwards. No dog discard-
ed a vaccine container that had not been punctured.
An estimation of the overall vaccination coverage
achieved during this field trial of dogs eligible for vacci-
nation (more than 2 months of age) was 76%, based on
the number of animals that accepted the bait and subse-
quently punctured the vaccine container (n = 116) or
were vaccinated by direct oral instillation (n = 17). The
vaccination coverage of the dog population, including
the puppies, was estimated at 61.6%.
Prior to and on the day of the vaccination campaign,
blood samples (BO) were collected from 14 animals; 12
samples from dogs offered a bait and 2 from animals vac-
cinated by direct administration of the vaccine virus into
the mouth cavity. All but two dogs tested negative (<0.5
IU/ml) for rabies VNA prior to the vaccination campaign
(geometric mean titre [GMT] = 0.10 IU/ml, s.d. = 0.34,
n = 14). The individual titres of the dogs were; 0.01, 0.03,
0.03, 0.04, 0.06, 0.06, 0.08, 0.10, 0.10, 0.11, 0.28, 0.29,
0.64 and 1.25 IU/ml. Fifteen and 29 days after the vacci-
nation campaign, subsequent blood samples could only
be collected from 8 of these 14 dogs. Several dogs per-
ished as a direct or indirect result of a typhoon that hit
the island 10 days after the campaign. Also, the owners of
other dogs were not able to relocate or restrain their
dogs, or simply refused to have their dog bled again.
Therefore, an additional six dogs were  selected, so a total
of 14 animals were bled on all three occasions. Six and 10
of 14 dogs had VNA titres ≥  0.5 IU/ml 15 and 29 days post
vaccination, respectively. The individual titres of the
dogs bled 15 days post vaccination were 0.05, 0.05, 0.07
(direct), 0.10, 0.13, 0.15, 0.15, 0.36, 0.50, 2.90, 3.93,
5.65, 8.28 and 24.60 IU/ml (GMT = 0.53, s.d. = 6.64).
The titres of the dogs sampled 29 days post vaccination
were 0.21, 0.23, 0.24, 0.35, 0.57, 1.08, 5.20 (direct), 5.61
(direct), 6.94, 13.12 (direct), 18.39, 26.86, 103.86 and
166.90 IU/ml (GMT = 3.58, s.d. = 49.03).
Risk assessment
No adverse reactions in dogs offered a bait or vaccinated
by direct oral instillation were reported from their own-
ers. Also, no deaths in other nontarget species (cat,
chicken, pig, rats) were reported. Unfortunately, only
three dogs, showing signs of illness, were collected and
examined for the presence of rabies virus; all animals
tested negative (FAT). Also, no human contacts with the
vaccine virus, direct or indirect, were reported.
Discussion
At the moment the only available method to control dog
rabies effectively is vaccination. For this purpose, a large
proportion of the dog population (75% or more) needs to
be immunised in order to interrupt the transmission cy-
cle within the population [1,25]. Unfortunately, many
dogs are inaccessible for vaccination by the parenteral
route in the Philippines. Evaluation of a mass parenteral
vaccination campaign in Sorsogon Province, Philippines,
indicated that between 47.4% and 75% of the dogs were
vaccinated, depending on the estimation technique used
[10]. In Mindoro, only 9.7% of the dogs could be handled
by the vaccinators without much trouble. Of course, the
number of dogs that can not be vaccinated by the
parenteral route within a population is variable, depend-
ing, among others, on the skills of the vaccinators to re-
strain the animals. Oral vaccination appears to offer a
new perspective in dog rabies control. In Sri Lanka, the
maximum vaccination coverage achieved through
parenteral vaccination and stray dog removal campaigns
was 60%. The vaccination coverage was increased to 72%
by use of supplementary oral vaccination [26]. In Kusa-
dasi, Turkey, 59% of all free-roaming dogs could not be
vaccinated by the parenteral route, but were accessible
for oral vaccination [8]. Oral vaccination will not only in-
crease the total number of dogs vaccinated, but also the
time-efficiency is greatly improved; offering a bait and
informing the dog owners will only take a fraction of theBMC Infectious Diseases 2001, 1:23 http://www.biomedcentral.com/1471-2334/1/23
time needed to catch, constrain and vaccinate by the
parenteral route the often free-roaming dogs. For exam-
ple, during a mass vaccination campaign in Metro Ma-
nila, Philippines, total person minutes spent per dog,
accessible for parenteral vaccination, was 13.96 minutes
[10].
In terms of efficacy of OVD field trials the primary indi-
cator of success is the vaccination coverage achieved [6].
During this field trial, 96.1% of the dog population aged
2 months or older accepted the bait without hesitation.
The high acceptance rate achieved was mainly a result of
the attractiveness of the bait used. Baits were quickly
taken up and most were rapidly and completely con-
sumed by the dogs. The advantage of a local-made bait
versus an imported manufactured bait are manifold. The
chances that dogs will not accept a bait, will increase with
growing unfamiliarity with the bait (texture, odour and
taste). Thus, baits made from local material have a con-
siderable advantage over imported manufactured baits.
In a field trial in Tunisia, only 44% of the free-roaming
owned dogs accepted a manufactured bait completely or
partially [27]. Another important advantage using local-
made baits are the costs; the price of the bait material
used in this trial was only U$0.01 [7]. Thus vaccine-baits
made from cheap material that is locally available will re-
duce the overall costs of OVD considerably compared to
imported manufactured vaccine baits. One should not
forget that a major obstacle for effective rabies control in
most countries with dog-mediated rabies are the limited
financial resources available for rabies control. Thus, the
cost-effectiveness of OVD will therefore be a decisive fac-
tor for the feasibility of this novel approach.
However, to evaluate the efficacy of the field trial, the es-
timated vaccination coverage based on the proportion of
animals accepting the bait is not sufficient. A more sen-
sitive method is the seroconversion rate of the dogs vac-
cinated. Although, the seroconversion rate is closely
linked with bait-uptake, the seroconversion rate is in
most cases lower than bait-uptake; e.g. a dog can sepa-
rate the vaccine container from the bait, or the vaccine
container is swallowed before it was punctured, so in
both cases no vaccine virus is released into the mouth
cavity.
In Mindoro, only 6 of 14 dogs had developed VNA liters
≥  0.5 IU/ml 15 days post-vaccination, two weeks later al-
ready 10 of 14 dogs had seroconverted above this thresh-
old. These serology results underscore the high
immunogenicity of SAD B19 [28]. Another live-modified
virus yielded much lower seroconversion rates; only 6 of
31 orally vaccinated laboratory beagles developed a titre
of ≥  0.5 IU/ml [29]. In a more recent study, 4 of 12 labo-
ratory dogs, vaccinated orally with a vaccine bait con-
taining this other oral rabies vaccine candidate,
developed VNA within 4 weeks post-vaccination. Unfor-
tunately, the antibodies did not persist very long, 4 weeks
post vaccination none of the animals had any detectable
VNA (≥  0.1 IU/ml) [30]. However, the concept of the ar-
bitrarily defined threshold (≥  0.5 IU/ml) has been ques-
tioned by several authors, since vaccinated dogs without
VNA, or well below this threshold, survived a subsequent
rabies challenge [29,30]. It seems that only cell-mediat-
ed immunity parameters correlate with protection in-
duced by rabies vaccination [31]. Although during a
recent study in foxes, it was shown that all vaccinated an-
imals that developed titres of ≥  0.5 IU/ml survived a
challenge, whereas all vaccinated foxes with titers <0.5
IU/ml succumbed to rabies [32]. The absence of detect-
able VNA can also indicate a vaccination failure. It is a
well known fact that malnourished dogs suffering from
nutritional deficiencies or animals with concurrent in-
fections or illnesses, like the dogs in Mindoro, can re-
spond sub optimally to vaccination [33,34].
Experimental and field studies clearly showed that it was
more difficult to elicit an immune response and subse-
quently achieve protection in indigenous dogs in devel-
oping countries after oral vaccination than in laboratory
dogs [11,16,35]. However, 5 of 6 local Turkish dogs of-
fered a boiled intestine bait, containing a SAD B19 filled
vaccine container, seroconverted (≥  0.5 IU/ml), and
were subsequently protected against rabies [36].
Although OVD was suggested as a supplementary tech-
nique to traditional parenteral vaccination, it seems that
in areas like Mindoro where all dogs are unrestricted and
only few animals are accessible for parenteral vaccina-
tion (within reasonable time and effort), it is more effi-
cient to use only oral vaccination. However, it should be
borne in mind that what is suitable for one country, may
not necessarily be most appropriate for another [10]. In
other countries, parenteral vaccination remains the core
of dog rabies control.
Unfortunately, the achieved vaccination coverage will
dimimish rapidly, due to the high population turnover.
The proportion of dogs less than 1 year of age (66%) in
Mindoro was extremely high. For example, Matter et al
[37] observed that only 22% of the owned dogs were less
than 1 year old in Banarli, a rural village in Turkey.
Hence, it may be necessary to conduct a vaccination
campaign every six months, in order to sustain the high
vaccination coverage attained. The high population turn-
over observed is not surprising considering the extreme-
ly biased sex ratio towards females. This is rather
unusual, most surveys indicate a surplus of male dogs
[38–42].BMC Infectious Diseases 2001, 1:23 http://www.biomedcentral.com/1471-2334/1/23
No vaccine virus induced rabies case was reported in the
target – and nontarget species. However, only few ani-
mals were collected for examination. The major reason
for this was a typhoon that hit the area approximately ten
days after the campaign. The village had to be evacuated
and the typhoon caused a lot of human suffering and ma-
terial damage. Thus, after returning to the village the
people were occupied with more important matters than
collecting samples and became increasingly hostile and
reluctant to cooperate; e.g. increasing demands for fi-
nancial compensation for dogs handed over for rabies di-
agnosis. The three dogs examined were all emaciated,
and two of them were diagnosed with acute respiratory
distress, possibly a result of the typhoon(s).
There was no reported case of human contact to the baits
and/or vaccine. The most obvious scenario is the direct
contact of a person through handling of a vaccine bait.
Exposure may also occur indirectly through contact with
a freshly vaccinated dog. Complementary excretion stud-
ies with swabbing at regular and frequent intervals after
vaccine instillation in local dogs, as suggested by the
WHO [6], were carried out during a previous experimen-
tal study at Don Mariano Marcos Memorial State Univer-
sity (DMMMSU); it was shown that after 60 minutes no
vaccine virus was detectable anymore in the saliva (Es-
trada, unpublished results). The chances of unintention-
al exposure of the vaccine virus to nontarget species,
especially humans, was further limited by the recollec-
tion of baits not accepted and the discarded vaccine con-
tainers. The absence of human contacts with the vaccine
virus is closely linked with the bait delivery system used.
Several other systems have been suggested; bait deposi-
tion at selected sites (similar to oral vaccination of wild-
life), or bait distribution to dog owners [27,43]. To reach
an acceptable vaccination coverage with the first system
would mean distributing an unrealistic number of thou-
sands of baits per km2[19,27,44], also the number of un-
intentional contacts of nontarget species (bait
competitors), including humans, will be unacceptable
high. In Istanbul, Turkey, 55.3% and 33.3% of baits
placed at selected sites were taken by nontarget species
during day-time and the evening, respectively [19]. Dis-
tribution of baits to dog owners was also not considered
suitable by the authors, due to the increased risks of hu-
man contacts with the vaccine virus. Ben Youssuf et al.
reported 25 unprotected human contacts during a field
trial with placebo vaccine baits in Tunisia; 1.7% of the to-
tal human population in the study-area [25].
Conclusions
The bait delivery system using baits made from cheap lo-
cally available material can be considered safe, effective
and cost-beneficial. A high vaccination coverage (76%)
as indicated by bait-acceptance was achieved among the
local dog population eligible for rabies vaccination. One
month post-vaccination, 71% (m= 14) of the dogs vacci-
nated had virus neutralizing antibody titres of ≥  0.5 IU/
ml. In terms of safety, no target and nontarget species ex-
posure to the vaccine virus was reported. Thus, the re-
sults of this first field trial indicate that oral vaccination
may be an effective tool in rabies control in the Philip-
pines.
Competing interests
The vaccine virus used, is produced by IDT GmbH, Ger-
many. One of the authors is an employee of this compa-
ny. Furthermore, the leading scientist of this study, Dr.
Roland Estrada, has received several training courses
abroad in the framework of this study. These were co-fi-
nanced by IDT GmbH.
Acknowledgements
First of all, we are very grateful to the members of National Rabies Com-
mittee and its Chairman, Dr. Atienza, for their support during the planning 
and implementation of this field trial. Also, the collaboration with the local 
authorities of Mindoro was much appreciated. Furthermore, we have to 
thank Jeanette Burow, Astrid Schameitat and Thomas Selhorst for their as-
sistance during the evaluation of the blood samples at Federal Research 
Centre for Virus Diseases of Animals, Wusterhausen, Germany. Finally, we 
have to express our gratitude to all the students of DMMMSU, Institute of 
Veterinary Medicine, who enthusiastically accompanied us to Mindoro on 
several occasions to assist us during all stages of the field trial.
References
1. Meslin FX, Miles MA, Vexenat A, Gemmell MA: Zoonoses Control
in dogs. In: Dogs, Zoonoses and Public Health. (Edited by MacPherson
CNL, Meslin FX, Wandeler AI) Wallingford, CABI Publishing 2000333-372
2. Fekadu M: Canine rabies. In: The Natural History of Rabies, 2nd Edition
(Edited by Baer GM) Boca Raton, CRC Press 1991367-378
3. Stöhr K, Meslin F-X: Progress and setbacks in the oral immuni-
sation of foxes against rabies in Europe. Vet Rec 1996, 139:32-35
4. Müller T, Schlüter H: Oral immunization of red foxes (Vulpes
vulpes L) in Europe: A review. J Etlik Vet Microbiol 1998, 9:35-59
5. Macinnes CD, Smith SM, Tinline RR, Ayers NR, Bachmann P, Ball
DGA, Calder LA, Crosgrey SJ, Fielding C, Hauschildt P, et al: Elimi-
nation of rabies from red foxes in eastern Ontario. J Wildi Dis
2001, 37:119-132
6. World Health Organization: Field application of oral rabies vac-
cines for dogs. World Health Organization, Geneva, 20–22
July 1998. Geneva 1998
7. Estrada RQ, Vos AC, De Leon RC: Acceptability of local-made
baits for oral vaccination of dogs against rabies in the Philip-
pines. BMC Inf Dis 2001, 1:19
8. Güzel N, Leloglu N, Vos A: Evaluation of a vaccination campaign
of dogs against rabies, including oral vaccination, in Kusadasi,
Turkey. J Etlik Vet Microbiol 1998, 9:121-134
9. Vos A, Aylan O: Oral immunization of dogs against rabies in
Turkey. Inf Circ – WHO Mediterr Zoon Control Cent 1999, 47:13-15
10. World Health Organization: Report of the fifth consultation on
oral immunization of dogs against rabies, Geneva, 20–22
June 1994. Geneva 1994
11. Müller W, Güzel T, Aylan O, Kaya C, Cox J, Schneider L: The feasi-
bility of oral vaccination of dogs in Turkey – an European Un-
ion supported project. J Etlik Vet Microbiol 1998, 9:61-71
12. Blancou J, Meslin F-X: Modified live-virus rabies vaccines for
oral immunization of carnivores. In: Laboratory techniques in ra-
bies, 4th edition (Edited by Meslin FX, Kaplan MM, Koprowski H) Geneva,
World Health Organization, 1996324-337
13. Schneider LG, Cox JH: Ein Feldversuch zur oralen Immunis-
ierung von Füchsen gegen die Tollwut in der Bundesrepublik
Deutschland. I. Unschädlichkeit, Wirksamkeit und Stabilität
der Vakzine SAD B19. Tierärztl Umschau 1983, 38:315-324BMC Infectious Diseases 2001, 1:23 http://www.biomedcentral.com/1471-2334/1/23
14. Vos A, Müller T, Schuster P, Schlüter H, Neubert A: Oral vaccina-
tion of foxes against rabies with SAD B19 in Europe, 1983–
1998: A review. Vet Bull 2000, 70:1-5
15. Aylan O: Safety tests of SAD B19 in Turkish dogs. J Etlik Vet
Microbiol 1998, 9:113-119
16. Aylan O, Vos A: Efficacy studies with SAD B19 in Turkish dogs.
J Etlik Vet Microbiol 1998, 9:93-101
17. Güzel T, Aylan O, Vos A: Innocuity tests of SAD B19 in Turkish
nontarget species. J Etlik Vet Microbiol 1998, 9:103-112
18. Schuster P, Gülsen N, Neubert A, Vos A: Field trials evaluating
bait uptake by an urban dog population in Turkey. J Etlik Vet
Microbiol 1998, 9:73-81
19. Vos A, Sanli S: Evaluation of a bait delivery system for oral vac-
cination of dogs against rabies in Turkey. J Etlik Vet Microbiol
1998, 9:83-91
20. Vos A, Neubert A, Aylan O, Schuster P, Pommerening E, Müller T,
Chai Chivatsi D: An update on safety studies of SAD B19 rabies
virus vaccine in target and non-target species. Epidem Infect
1999, 123:165-175
21. Smith JS, Yager PA, Baer GM: A rapid reproducible test for de-
termining rabies neutralizing antibody. Bull World Health Organz
1973, 48:535-541
22. Cox JH, Schneider LG: Prophylactic immunization of humans
against rabies by intradermal inoculation of human diploid
cell culture vaccine. J Clin Microbiol 1976, 3:96-101
23. Wandeler AI, Bingham J: Dogs and Rabies. In: Dogs, Zoonoses and
Public Health. (Edited by MacPherson CNL, Meslin FX, Wandeler AI) Wall-
ingford, CABI Publishing 200063-90
24. Dean DJ, Abelseth MK, Athanasiu P P: The fluorescence antibody
test. In: Laboratory techniques in rabies, 4 edition (Edited by Meslin FX,
Kaplan MM, Koprowski H) Geneva, World Health Organization, 199688-
93
25. Ben Youssef S, Matter HC, Schumacher CL, Kharmachi H, Jemli J,
Mrabet L, Gharbi M, Hammami S, ElHicheri K, Aubert MFA, et al:
Field evaluation of a dog owner, participation-based, bait de-
livery system for the oral immunization of dogs against ra-
bies in Tunesia. Am J Trop Med Hyg 1998, 58:835-845
26. Harischandra PAI: Increasing dog vaccination coverage in Sri
Lanka: Is oral vaccination the answer? In: Fourth International
Symposium on Rabies Control in Asia, 5–9 March 2001, Hanoi, Vietnam.
Abstract Book, 2001117
27. Matter HC, Schumacher CL, Kharmachi H, Hammami S, Tlatli A, Jemli
J, Mrabet L, Meslin FX, Aubert MFA, Neuenschwander BE, et al: Field
evaluation of two bait delivery systems for the oral immuni-
zation of dogs against rabies in Tunisia. Vaccine 1998, 16:657-
665
28. Neubert A, Schuster P, Tüller M, Vos A, Pommerening E: Immuno-
genicity and Efficacy of the Oral Rabies Vaccine SAD B19 in
Foxes. J Vet Med B 2001, 49:179-183
29. Rupprecht CE, Shaddock JS, Sanderlin DW, Hanlon CA, Niezgoda M,
Schumacher CL: Oral Rabies Vaccination of Dogs. Israel J Vet Med
1998, 34:228-239
30. Orciari L, Niezgoda M, Hanlon CA, Shaddock JH, Sanderlin DW, Yag-
er PA, Rupprecht CE: Rapid clearance of SAG-2 rabies virus
from dogs after oral vaccination. Vaccine 2001, 19:4511-4518
31. Zanettti CR, De Franco MT, Vassao RC, Pereira CA, Pereira OAC:
Failure of protection induced by a Brazilian vaccine against
Brazilian wild rabies viruses. Arch Virol 1998, 143:1745-1756
32. Müller TF, Schuster P, Vos AC, Selhorst T, Wenzel UD, Neubert AM:
Effect of maternal immunity on the immune response to
oral vaccination against rabies in young foxes. Am J Vet Res
2001, 62:1154-1158
33. Ford RB: Vaccines and vaccination. Issues for the 21st centu-
ry. Suppl Compend Contin Educ Pract. Vet 1998, 20:19-24
34. Robinson RA: Zoonoses and immunosuppressed populations.
In: Dogs, Zoonoses and Public Health (Edited by MacPherson CNL, Meslin
FX, Wandeler AI) Wallingford, CABI Publishing 2000273-298
35. Schumacher CL, Bishop G, Bingham J, Hammami S, Chaparro F, Von
Teichman BF, Aubert MFA, Cliquet F, Aubert A: Protection, sero-
conversion and safety results of SAG2 in indigenous and lab-
oratory dogs.  In: Abstracts IX International Meeting on Research
Advances and Rabies Control in the Americas, December 8–12, Puerto Val-
larta, Mexico 199843-44
36. Aylan O, Vos A: Efficacy of oral rabies vaccine baits in indige-
nous Turkish dogs. Inf Dis Rev 2000, 2:74-77
37. Matter H, Fico R, Neuenschwander BE: Study of the structure and
density of a dog population in Tekirdag (Turkey). J Etlik Vet
Microbiol 1998, 9:9-24
38. Beck AM: The ecology of stray dogs: a study of free-ranging
urban animals. Baltimore, York Press 1973
39. Daniels TJ, Bekoff M: Population and social biology of free-rang-
ing dogs, Canis familiaris. J Mamm 1989, 70:754-762
40. Vos A, Turan B: Study of the dog population in Istanbul, Tur-
key. J Etlik Vet Microbiol 1998, 9:25-34
41. Matter HC, Daniels TJ: Dog ecology and population biology. In:
Dogs, Zoonoses and Public Health. (Edited by MacPherson CNL, Meslin FX,
Wandeler AI) Wallingford, CABI Publishing 200017-62
42. Pal SK: Population ecology of free-ranging urban dogs in West
Bengal, India. Acta Theriol 2001, 46:69-78
43. Linhart SB: Bait formulation and distribution for oral rabies
vaccination of domestic dogs: an overview. Onderstepoort J Vet
Res 1993, 60:479-490
44. Gleixner A, Meyer H, Aylan O, Vos A: The delivery of baits to
dogs: clenbuterol as baitmarker. J Etlik Vet Microbiol 1998, 9:135-
142
Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com